Novel venetoclax combination therapy advancing the field of CLL
In chronic lymphocytic leukemia (CLL), venetoclax has established itself as one of the most effective monotherapies in certain contexts. Speaking from the American Society of Hematology (ASH) 2017 Ann...
Author: VJHemOnc
Added: 12/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia